Author:
Xia Xuelin,Yang Xiaoyuan,Gao Wenhui,Huang Wei,Xia Xiaoxia,Yan Deyue
Funder
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Reference46 articles.
1. Bollag DM, McQueney PA, Zhu J, Hensens O, Koupal L, Liesch J, et al. Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action. Cancer Res. 1995;55:2325–33.
2. Höfle G, Bedorf N, Steinmetz H, Schomburg D, Gerth K, Reichenbach H. Epothilone A and B—novel 16-membered macrolides with cytotoxic activity: isolation, crystal structure, and conformation in solution. Angew Chem Int Ed. 1996;35:1567–9.
3. Nicolaou KC, Rhoades D, Wang Y, Bai R, Hamel E, Aujay M, et al. 12, 13-Aziridinyl epothilones. Stereoselective synthesis of trisubstituted olefinic bonds from methyl ketones and heteroaromatic phosphonates and design, synthesis, and biological evaluation of potent antitumor agents. J Am Chem Soc. 2017;139:7318–34.
4. Giannakakou P, Gussio R, Nogales E, Downing KH, Zaharevitz D, Bollbuck B, et al. A common pharmacophore for epothilone and taxanes: molecular basis for drug resistance conferred by tubulin mutations in human cancer cells. Proc Natl Acad Sci USA. 2000;97:2904–9.
5. Zhang P, Zhang L, Jiang X, Diao XT, Li S, Li DD. Docking-guided rational engineering of a macrolide glycosyltransferase glycodiversifies epothilone B. Commun Biol. 2022;5:100.